AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 1 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,000 | -30.8% | 566 | -65.4% | 0.00% | – |
| Q3 2022 | $13,000 | +30.0% | 1,636 | +4.5% | 0.00% | – |
| Q2 2022 | $10,000 | -16.7% | 1,565 | -28.5% | 0.00% | – |
| Q1 2022 | $12,000 | +9.1% | 2,190 | -10.1% | 0.00% | – |
| Q4 2021 | $11,000 | 0.0% | 2,435 | +50.8% | 0.00% | – |
| Q3 2021 | $11,000 | 0.0% | 1,615 | -1.5% | 0.00% | – |
| Q2 2021 | $11,000 | -21.4% | 1,640 | -13.9% | 0.00% | – |
| Q1 2021 | $14,000 | +100.0% | 1,904 | +56.1% | 0.00% | – |
| Q4 2020 | $7,000 | +250.0% | 1,220 | +269.7% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 330 | -23.3% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 430 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $23,481,000 | 0.99% |
| Cormorant Asset Management, LP | 1,000,000 | $5,940,000 | 0.23% |
| WealthTrust Axiom LLC | 22,347 | $132,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 100,000 | $594,000 | 0.05% |
| Virtu Financial LLC | 24,577 | $146,000 | 0.02% |
| PDT Partners, LLC | 61,839 | $367,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 26,039 | $155,000 | 0.02% |
| MGO ONE SEVEN LLC | 10,000 | $59,000 | 0.01% |
| WINTON GROUP Ltd | 45,208 | $269,000 | 0.01% |
| Ancora Advisors LLC | 36,350 | $216,000 | 0.01% |